203 related articles for article (PubMed ID: 33723248)
1. Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models.
Riess C; Koczan D; Schneider B; Linke C; Del Moral K; Classen CF; Maletzki C
Cell Death Discov; 2021 Mar; 7(1):54. PubMed ID: 33723248
[TBL] [Abstract][Full Text] [Related]
2. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer.
Kayser A; Wolff A; Berlin P; Duehring L; Henze L; Mundkowski R; Bergmann W; Müller-Hilke B; Wagner C; Huehns M; Oehmcke-Hecht S; Maletzki C
Sci Rep; 2024 May; 14(1):10582. PubMed ID: 38719932
[TBL] [Abstract][Full Text] [Related]
3. PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro.
Perry JR; Genenger B; Thind AS; Ashford B; Ranson M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254859
[TBL] [Abstract][Full Text] [Related]
4. Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways.
Teng CJ; Cheng PT; Cheng YC; Tsai JR; Chen MC; Lin H
Toxicol In Vitro; 2024 Apr; 96():105768. PubMed ID: 38135130
[TBL] [Abstract][Full Text] [Related]
5. ClonoScreen3D - A Novel 3-Dimensional Clonogenic Screening Platform for Identification of Radiosensitizers for Glioblastoma.
Jackson MR; Richards AR; Oladipupo AA; Chahal SK; Caragher S; Chalmers AJ; Gomez-Roman N
Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38493899
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
Wander SA; Han HS; Zangardi ML; Niemierko A; Mariotti V; Kim LSL; Xi J; Pandey A; Dunne S; Nasrazadani A; Kambadakone A; Stein C; Lloyd MR; Yuen M; Spring LM; Juric D; Kuter I; Sanidas I; Moy B; Mulvey T; Vidula N; Dyson NJ; Ellisen LW; Isakoff S; Wagle N; Brufsky A; Kalinsky K; Ma CX; O'Shaughnessy J; Bardia A
J Natl Compr Canc Netw; 2021 Mar; ():1-8. PubMed ID: 33761455
[TBL] [Abstract][Full Text] [Related]
7. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
[TBL] [Abstract][Full Text] [Related]
8. Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Kankeu Fonkoua LA; Chakrabarti S; Sonbol MB; Kasi PM; Starr JS; Liu AJ; Nevala WK; Maus RL; Bois MC; Pitot HC; Chandrasekharan C; Ross HJ; Wu TT; Graham RP; Villasboas JC; Weiss M; Foster NR; Markovic SN; Dong H; Yoon HH
Int J Cancer; 2021 Jul; 149(2):378-386. PubMed ID: 33739449
[TBL] [Abstract][Full Text] [Related]
9.
Luo SM; Tsai WC; Tsai CK; Chen Y; Hueng DY
Onco Targets Ther; 2021; 14():1843-1855. PubMed ID: 33732001
[TBL] [Abstract][Full Text] [Related]
10. Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing.
Kim JH; An GH; Kim JY; Rasaei R; Kim WJ; Jin X; Woo DH; Han C; Yang SR; Kim JH; Hong SH
Cell Death Discov; 2021 Mar; 7(1):48. PubMed ID: 33723255
[TBL] [Abstract][Full Text] [Related]
11. Post-translational modifications: Regulators of neurodegenerative proteinopathies.
Gupta R; Sahu M; Srivastava D; Tiwari S; Ambasta RK; Kumar P
Ageing Res Rev; 2021 Jul; 68():101336. PubMed ID: 33775891
[TBL] [Abstract][Full Text] [Related]
12. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
13. Cancer-specific loss of
Amen AM; Fellmann C; Soczek KM; Ren SM; Lew RJ; Knott GJ; Park JE; McKinney AM; Mancini A; Doudna JA; Costello JF
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33758097
[TBL] [Abstract][Full Text] [Related]
14. Role of iron and iron-related proteins in mesenchymal stem cells: Cellular and clinical aspects.
Mehta KJ
J Cell Physiol; 2021 Oct; 236(10):7266-7289. PubMed ID: 33821487
[TBL] [Abstract][Full Text] [Related]
15. Unique metabolic phenotype and its transition during maturation of juvenile male germ cells.
Voigt AL; Kondro DA; Powell D; Valli-Pulaski H; Ungrin M; Stukenborg JB; Klein C; Lewis IA; Orwig KE; Dobrinski I
FASEB J; 2021 May; 35(5):e21513. PubMed ID: 33811704
[TBL] [Abstract][Full Text] [Related]
16. Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation.
Wang W; Fang F; Ozes A; Nephew KP
Mol Cancer Ther; 2021 Jun; 20(6):1092-1101. PubMed ID: 33785648
[TBL] [Abstract][Full Text] [Related]
17. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.
Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K
Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of RTA 404 in Human Brain Malignant Glioma Cell Lines via Cell Cycle Arrest via p21/AKT Signaling.
Tsai TH; Lieu AS; Wang YW; Yang SF; Hsu YC; Lin CL
Biomed Res Int; 2021; 2021():5552226. PubMed ID: 33763472
[TBL] [Abstract][Full Text] [Related]
20. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer.
Li X; Zheng J; Chen S; Meng FD; Ning J; Sun SL
Cell Death Dis; 2021 Mar; 12(4):314. PubMed ID: 33762577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
